Embla Medical hf - Company Profile
Powered by 
All the sales intelligence you need on Embla Medical hf in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Embla Medical hf fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Embla Medical hf.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Embla Medical hf (Embla), formerly Ossur hf, is an orthopedic device company. It mainly focuses on prosthetics, neuro orthotics, bracing and supports, and patient care services. The company's major products include ankle and foot supports; neck and spine support products; ; walkers, knee braces; bandages; and lower limb prosthetics, including liners, knees, and feet. It offers the products to customers through the brands Ossur, Fior and Gentz, College Park, and ForMotion. The company distributes its products through a network of Orthotic and Prosthetic clinics and healthcare providers. It has manufacturing facilities in the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Embla is headquartered in Reykjavik, Iceland.
Headquarters
Iceland
Address
Grjothals 5, Reykjavik, 110
Website
www.emblamedical.com
No of Employees
4,192
Industry
Medical Equipment
Ticker Symbol & Exchange
EMBLA (CPH)
Revenue (2025)
$928.7M
8.6%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
22.1%
(2025 vs 2024)
Market Cap*
$1.8B
Net Profit Margin (2025)
XYZ
12.3%
(2025 vs 2024)
* As of and is in US$
Embla Medical hf premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | Fior & Gentz |
| Prosthetic Solutions: | Össur |
| Lower-limb Prosthetic Components | College Park |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In November, the company launched its new prosthetic clinic in Kyiv, Ukraine. |
| 2025 | Financing Agreements | In August, the company invested a majority share in Streifeneder ortho.production. |
| 2025 | Contracts/Agreements | In July, the company entered into an agreement to invest in a majority share in Streifeneder ortho.production GmbH. |
Competitor Comparison
| Key Parameters | Embla Medical hf | Ottobock SE & Co KGaA | Cochlear Ltd | Medacta Group SA | Modern Dental Group Ltd |
|---|---|---|---|---|---|
| Headquarters | Iceland | Germany | Australia | Switzerland | Hong Kong |
| City | Reykjavik | Duderstadt | Sydney | Castel San Pietro | Hong Kong |
| State/Province | - | Niedersachsen | New South Wales | - | - |
| No. of Employees | 4,192 | 9,300 | 5,500 | 2,165 | 8,538 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Niels Jacobsen | Chairman | Executive Board | 2006 | 69 |
| Sveinn Solvason | President; Chief Executive Officer | Senior Management | 2022 | 48 |
| Lukas Marklin | Chief Operating Officer | Senior Management | 2023 | 52 |
| Olafur Gylfason | Executive Vice President - Chronic Solutions | Senior Management | 2022 | 57 |
| Svafa Gronfeldt | Vice Chairman | Executive Board | 2021 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer